404 results
Page 4 of 21
8-K
EX-10.2
868rx5l7i
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
8-K
EX-10.1
9tyncuw
10 Jul 20
Entry into a Material Definitive Agreement
4:41pm
424B3
by1jc7
29 Jun 20
Prospectus supplement
12:00am
424B5
yfcx8vvh7
26 May 20
Prospectus supplement for primary offering
4:02pm
8-K
EX-10.1
zki8b vnw2bum
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-10.2
fpy czgm1k2mvpcp
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
8-K
EX-4.1
ul29hy50 b0bo7zblt
26 May 20
Caladrius Biosciences Announces $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
8:02am
424B5
c4mguly
27 Apr 20
Prospectus supplement for primary offering
7:30am
8-K
EX-10.2
1m7855nzc 6ch
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm
8-K
EX-4.1
izjo1k bi0nvi2sivg
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm
8-K
EX-10.1
troq3vextm
24 Apr 20
Caladrius Biosciences Announces $5.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:02pm
424B5
x8uc8
20 Mar 19
Prospectus supplement for primary offering
5:19pm
424B5
ok1fs c70dw
14 Mar 19
Prospectus supplement for primary offering
4:23pm